Results for tag: "Lung Cancer Diagnostics"

The Lung Cancer Diagnostics market is a subset of the larger Diagnostics industry. It is focused on the development and commercialization of tests and technologies that can detect and diagnose lung cancer. These tests can range from imaging techniques such as X-ray, CT scan, and MRI, to molecular tests such as gene sequencing and biomarker analysis. The goal of these tests is to detect lung cancer at an early stage, when it is most treatable. The Lung Cancer Diagnostics market is highly competitive, with many companies offering a variety of tests and technologies. Some of the major players in the market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Hologic, and Becton Dickinson. Show Less Read more